$203 Million is the total value of Mohican Financial Management, LLC's 42 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
INFINERA CORPORATIONdbcv 1.750% 6/0 | $6,641,000 | +18.8% | 5,000,000 | 0.0% | 3.26% | +19.7% | ||
M/I HOMES INCnote 3.250% 9/1 | $5,112,000 | +5.1% | 4,300,000 | 0.0% | 2.51% | +5.9% | ||
ENDOLOGIX INCnote 2.250%12/1 | $4,891,000 | +9.0% | 5,000,000 | 0.0% | 2.40% | +9.8% | ||
ARRAY BIOPHARMA INCnote 3.000% 6/0 | $3,270,000 | +5.6% | 3,500,000 | 0.0% | 1.61% | +6.4% | ||
VXZ | BARCLAYS BK PLCipath s&p mt etn | $332,000 | 0.0% | 25,300 | 0.0% | 0.16% | +0.6% | |
SOLAZYME INCnote 5.000%10/0 | $228,000 | -49.3% | 500,000 | 0.0% | 0.11% | -49.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-01-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENCORE CAP GROUP INC | 24 | Q2 2020 | 6.7% |
TTM TECHNOLOGIES INC | 23 | Q2 2020 | 7.2% |
RENEWABLE ENERGY GROUP INC | 18 | Q3 2018 | 5.3% |
GLOBAL EAGLE ENTMT INC | 18 | Q3 2020 | 4.0% |
M/I HOMES INC | 17 | Q2 2017 | 3.1% |
THERAVANCE BIOPHARMA INC | 15 | Q2 2020 | 2.4% |
ASCENT CAP GROUP INC | 15 | Q1 2017 | 1.6% |
QUIDEL CORP | 14 | Q1 2018 | 7.3% |
HEALTHWAYS INC | 14 | Q2 2017 | 5.3% |
ALTRA INDL MOTION CORP | 14 | Q3 2016 | 5.2% |
View Mohican Financial Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-07-28 |
13F-HR | 2021-04-29 |
13F-HR | 2021-01-14 |
13F-HR | 2020-10-20 |
13F-HR | 2020-07-20 |
13F-HR | 2020-04-29 |
13F-HR | 2020-01-28 |
13F-HR | 2019-10-25 |
13F-HR | 2019-07-11 |
13F-HR | 2019-04-23 |
View Mohican Financial Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.